APPLIED GENETIC TECHNOLOGIES CORP (AGTC) is a publicly traded company in the Unknown sector. Across all available filings, 24 corporate insiders have executed 130 transactions totaling $21.8M, demonstrating a bearish sentiment with -$3.9M in net insider flow. The most recent transaction on Nov 30, 2022 involved a transaction of 143,021 shares valued at $0.
No significant insider buying has been recorded for AGTC in the recent period.
No significant insider selling has been recorded for AGTC in the recent period.
Based on recent SEC filings, insider sentiment for AGTC is bearish with an Insider Alignment Score of 41/100 and a net flow of -$3.9M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at APPLIED GENETIC TECHNOLOGIES CORP (AGTC) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 24 insiders are actively trading AGTC stock, having executed 130 transactions in the past 90 days. The most active insider is Plc Glaxosmithkline (Executive), who has made 8 transactions totaling $13.4M.
Get notified when executives and directors at AGTC file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Nov 30, 2022 | B. Washer Susan | Executive | Tender | 143,021 | $N/A | $0 | |
| Nov 30, 2022 | W. Potter Stephen | Executive | Tender | 47,133 | $N/A | $0 | |
| Nov 30, 2022 | W. Potter Stephen | Executive | Disposition | 8,750 | $N/A | $0 | |
| Nov 30, 2022 | Anthony Reynolds Gerald | Executive | Tender | 8,506 | $N/A | $0 | |
| Nov 30, 2022 | Anthony Reynolds Gerald | Executive | Disposition | 42,500 | $N/A | $0 | |
| Nov 30, 2022 | Koenig Scott | Executive | Tender | 34,246 | $N/A | $0 | |
| Nov 30, 2022 | Hurwitz Edward | Executive | Tender | 1,800 | $N/A | $0 | |
| Nov 30, 2022 | Hurwitz Edward | Executive | Tender | 25,672 | $N/A | $0 | |
| Nov 30, 2022 | Aliski William | Executive | Tender | 8,500 | $N/A | $0 | |
| Nov 30, 2022 | Rosen James | Executive | Tender | 1,000 | $N/A | $0 | |
| Aug 21, 2022 | Anthony Reynolds Gerald | Executive | Award | 30,000 | $N/A | $0 | |
| Jul 1, 2022 | W. Potter Stephen | Executive | Sale | 8,070 | $0.77 | $6.2K | |
| May 27, 2022 | Anthony Reynolds Gerald | Executive | Sale | 3,994 | $0.85 | $3.4K | |
| Feb 18, 2022 | B. Washer Susan | Executive | Option Exercise | 120,686 | $0.35 | $42.2K | |
| Feb 18, 2022 | B. Washer Susan | Executive | Sale | 9,950 | $2.18 | $21.7K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 14 | $12.8M | 57.9% |
Purchase(P) | 21 | $8.9M | 40.4% |
Exercise(M) | 14 | $194.1K | 0.9% |
Payment(F) | 27 | $183.9K | 0.8% |
Tender(U) | 8 | $0 | 0.0% |
Disposition(D) | 2 | $0 | 0.0% |
Award(A) | 27 | $0 | 0.0% |
Other(J) | 3 | $0 | 0.0% |
Exercise (Options)(X) | 3 | $0 | 0.0% |
Gift(G) | 3 | $0 | 0.0% |
Conversion(C) | 8 | $0 | 0.0% |
Insider activity at APPLIED GENETIC TECHNOLOGIES CORP shows mixed signals across all time. While $8.9M in purchases indicates some executive confidence,$12.8M in sales balances the picture, resulting in a modest net flow of -$3.9M.24 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Plc Glaxosmithkline, has transacted $13.4M during this period.